Justin B. Klee, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 30,464 shares at $32.13 ($980K) on 2026-09-10, disclosed to the SEC on 2026-09-14.
Open-market sale of $980k AMLX by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.13 | 29,025 | $933K | 95.1% |
| 2 | $33.16 | 1,439 | $48K | 4.9% |
| Total | $32.18 avg | 30,464 | $980K | 100% |
| Filing → |
| AMLX | SELL | 2026-01-20 | $3.8M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $859K | — | Filing → |